Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents
- 31 December 1993
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (14) , 2009-2014
- https://doi.org/10.1016/0959-8049(93)90463-p
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI Journal of the National Cancer Institute, 1992
- Taxol: A new agent active in melanoma and ovarian cancerPublished by Springer Nature ,1992
- Mechanism of action of taxolTrends in Pharmacological Sciences, 1992
- The chemistry of taxolPharmacology & Therapeutics, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- New Natural Products in Cancer ChemotherapyThe Journal of Clinical Pharmacology, 1990
- Biphasic Effect of Vanadium Salts on In Vitro Tumor Colony GrowthThe International Journal of Cell Cloning, 1987
- The human tumor cloning assay in cancer research and therapy: A review with clinical correlationsCurrent Problems in Cancer, 1985
- In vitro activation of dacarbazine (DTIC) for a human tumor cloning systemThe International Journal of Cell Cloning, 1983
- Tumor stem cell cloning in agar-containing capillariesThe Science of Nature, 1981